Skip to main content

Table 2 Cox regression analysis for death and/or hospitalization with heart failure at minimum 6 month follow-up

From: Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction – implications for clinical trials

 

Univariate model, HR (95% CI)

p

Multivariate model, HR (95% CI)

p

Demographics

 Age

1.01 (0.99–1.05)

0.34

  

 Gender

1.48 (0.84–2.60)

0.17

  

Clinical Findings

 Heart rate (b.p.m)

1.00 (0.98–1.02)

0.64

  

 Systolic blood pressure (mmHg)

1.00 (0.98–1.01)

0.38

  

 Diastolic blood pressure (mmHg)

0.97 (0.95–1.00)

0.03

0.99 (0.97–1.02)

0.48

 NYHA III/IV

1.80 (1.02–3.17)

0.04

1.55 (0.83–2.89)

0.17

Medical history

    

 Hypertension

2.40 (0.58–9.87)

0.23

  

 Diabetes

1.03 (0.59–1.79)

0.91

  

Biochemistry

 Sodium (mmol/L)

0.97 (0.90–1.05)

0.45

  

 Urea (mmol/L)

1.09 (1.02–1.15)

0.01

1.10 (1.01–1.21)

0.04

 eGFR (ml/min per 1.73m2)

0.99 (0.97–1.00)

0.07

1.01 (0.99–1.03)

0.37

 ZLog BNP (ng/L)

1.47 (1.08–2.01)

0.02

1.44 (1.03–2.02)

0.03

CMR findings

 New diagnoses group

1.75 (1.00–3.07)

0.05

1.92 (1.06–3.45)

0.03

  1. Abbreviations are as for Table 1 and HR hazard ratio, CI confidence interval